American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Bajorin
    Bajorin
  3. Bosl
    Bosl
  4. Scher
    Scher
  5. Sheinfeld
    Sheinfeld
  6. Herr
    Herr
  7. Russo
    Russo
  8. Schwartz
    Schwartz
  9. Bains
    Bains
  10. Reuter
    Reuter

Groups

  1. Department of Medicine (43)
  2. Solid Tumor Oncology Division (43)
  3. Genitourinary Oncology Service (40)
  4. Surgery (26)
  5. Survivorship Research (23)
  6. Urology (20)
  7. Radiology, Department of (7)
  8. Body Imaging Service (6)
  9. Nursing (5)
  10. Division of Subspecialty Medicine (3)
Search Within
  1. "Madhu Mazumdar"
Formats
  1. Journal Article (43)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (43)
  2. Solid Tumor Oncology Division (43)
  3. Genitourinary Oncology Service (40)
  4. Surgery (26)
  5. Survivorship Research (23)
  6. Urology (20)

More Groups

People
  1. Madhu Mazumdar (48)
  2. Robert Motzer (29)
  3. Dean Bajorin (27)
  4. George Bosl (21)
  5. Jennifer Bacik (19)
  6. Vaia Vlamis (12)

More People

Years
  1. 2011 (1)
  2. 2007 (2)
  3. 2005 (5)
  4. 2004 (5)
  5. 2003 (2)
  6. 2002 (5)

More Years

Publications
  1. Journal of Clinical Oncology (48)

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Tagawa, S. T.; Saran, A.; Akhtar, N. H.; Goel, S.; Mileo, G.; Kung, S.; Beltran, H.; Milowsky, M. I.; Mazumdar, M.; Wright, J. J.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
    Journal Article

    Motzer, R. J.; Nichols, C. J.; Margolin, K. A.; Bacik, J.; Richardson, P. G.; Vogelzang, N. J.; Bajorin, D. F.; Lara, P. N. Jr; Einhorn, L.; Mazumdar, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors
    Journal Article

    Kondagunta, G. V.; Bacik, J.; Sheinfeld, J.; Bajorin, D.; Bains, M.; Reich, L.; Deluca, J.; Budnick, A.; Ishill, N.; Mazumdar, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Robustness of response: A new measure of response assessment: Its impact on metricies of response in colorectal cancer
    Meeting Abstract

    Wang, L.; Schwartz, L. H.; Mazumdar, M.; Smith, A.; Kemeny, N. E.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prognostic factors for survival in patients with metastatic renal cell carcinoma: A study from the Kidney Cancer Association's International Kidney Cancer Working Group (IKCWG)
    Meeting Abstract

    Elson, P. J.; Manola, J. B.; Mazumdar, M.; Bacik, J. M.; Supers, S. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: A highly lethal subset associated with poor chemoresponse
    Journal Article

    Huang, H. Y.; Illei, P. B.; Zhao, Z.; Mazumdar, M.; Huvos, A. G.; Healey, J. H.; Wexler, L. H.; Gorlick, R.; Meyers, P.; Ladanyi, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point
    Journal Article

    Guillem, J. G.; Chessin, D. B.; Shia, J.; Moore, H. G.; Mazumdar, M.; Bernard, B.; Paty, P. B.; Saltz, L.; Minsky, B. D.; Weiser, M. R.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Recent chemotherapy reduces the sensitivity of [18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases
    Journal Article

    Akhurst, T.; Kates, T. J.; Mazumdar, M.; Yeung, H.; Riedel, E. R.; Burt, B. M.; Blumgart, L.; Jarnagin, W.; Larson, S. M.; Fong, Y.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Etoposide and cisplatin (EP) chemotherapy for good risk germ cell tumors (GCT): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Kondagunta, G. V.; Bacik, J.; Bajorin, D.; Mazumdar, M.; Dobrzynski, D.; Sheinfeld, J.; Motzer, R. J.; Bosl, G. J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Clinical assessment following preoperative combined modality therapy (CMT) for rectal carcinoma does not accurately predict pathologic response: A prospective analysis
    Meeting Abstract

    Chessin, D. B.; Shia, J.; Mazumdar, M.; Moore, H. G.; Paty, P.; Saltz, L.; Minsky, B.; Cohen, A. M.; Wong, W. D.; Guillem, J. G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save